262 related articles for article (PubMed ID: 8939746)
1. Human rhinovirus 3 at 3.0 A resolution.
Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
[TBL] [Abstract][Full Text] [Related]
2. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
Kim KH; Willingmann P; Gong ZX; Kremer MJ; Chapman MS; Minor I; Oliveira MA; Rossmann MG; Andries K; Diana GD
J Mol Biol; 1993 Mar; 230(1):206-27. PubMed ID: 8383771
[TBL] [Abstract][Full Text] [Related]
4. Structure of human rhinovirus serotype 2 (HRV2).
Verdaguer N; Blaas D; Fita I
J Mol Biol; 2000 Jul; 300(5):1179-94. PubMed ID: 10903863
[TBL] [Abstract][Full Text] [Related]
5. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
6. The structure of human rhinovirus 16.
Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human rhinovirus serotype 1A (HRV1A).
Kim SS; Smith TJ; Chapman MS; Rossmann MC; Pevear DC; Dutko FJ; Felock PJ; Diana GD; McKinlay MA
J Mol Biol; 1989 Nov; 210(1):91-111. PubMed ID: 2555523
[TBL] [Abstract][Full Text] [Related]
8. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
[TBL] [Abstract][Full Text] [Related]
9. Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule.
Xiao C; Tuthill TJ; Bator Kelly CM; Challinor LJ; Chipman PR; Killington RA; Rowlands DJ; Craig A; Rossmann MG
J Virol; 2004 Sep; 78(18):10034-44. PubMed ID: 15331736
[TBL] [Abstract][Full Text] [Related]
10. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM
Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
12. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes.
Lentz KN; Smith AD; Geisler SC; Cox S; Buontempo P; Skelton A; DeMartino J; Rozhon E; Schwartz J; Girijavallabhan V; O'Connell J; Arnold E
Structure; 1997 Jul; 5(7):961-78. PubMed ID: 9261087
[TBL] [Abstract][Full Text] [Related]
13. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.
Hadfield AT; Diana GD; Rossmann MG
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14730-5. PubMed ID: 10611281
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
[TBL] [Abstract][Full Text] [Related]
15. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics investigation of the effect of an antiviral compound on human rhinovirus.
Phelps DK; Post CB
Protein Sci; 1999 Nov; 8(11):2281-9. PubMed ID: 10595531
[TBL] [Abstract][Full Text] [Related]
17. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
Speelman B; Brooks BR; Post CB
Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
[TBL] [Abstract][Full Text] [Related]
19. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity.
Andries K; Dewindt B; Snoeks J; Wouters L; Moereels H; Lewi PJ; Janssen PA
J Virol; 1990 Mar; 64(3):1117-23. PubMed ID: 2154596
[TBL] [Abstract][Full Text] [Related]
20. Cations in human rhinoviruses.
Zhao R; Hadfield AT; Kremer MJ; Rossmann MG
Virology; 1997 Jan; 227(1):13-23. PubMed ID: 9007054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
